Hanover, Germany

Julia Suerth

This inventor holds 1 USPTO granted patent. Top assignee: Medizinische Hochschule Hannover. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julia Suerth: Innovator in Viral Vector Technology

Introduction

Julia Suerth is a prominent inventor based in Hanover, DE. She has made significant contributions to the field of viral vector technology, particularly through her innovative work on the ASLV vector system. Her research focuses on developing advanced tools for gene therapy and other therapeutic applications.

Latest Patents

Julia Suerth holds 1 patent for her invention of the ASLV vector system. This invention provides a viral self-inactivating (SIN) vector based on the avian sarcoma leukosis virus (ASLV). The system includes a split-packaging mechanism that comprises a first helper plasmid for expressing the viral fusion protein gag-pol and a second helper plasmid for expressing the retroviral envelope protein env. This innovative approach allows for the generation of non-replicating viral particles that can carry therapeutically effective RNA, which may include a transgene.

Career Highlights

Julia Suerth is affiliated with the Medizinische Hochschule Hannover, where she continues her research and development in viral vector systems. Her work has been instrumental in advancing the understanding and application of gene therapy techniques.

Collaborations

Julia collaborates with Christopher Baum, a fellow researcher, to further explore the potential of her inventions in therapeutic applications.

Conclusion

Julia Suerth's contributions to viral vector technology exemplify her commitment to advancing medical science. Her innovative ASLV vector system represents a significant step forward in the field of gene therapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…